Swetox involved in setting the regulatory guidelines for nanomedicine

Immune Toxicologist Karin Cederbrant at Swetox in Södertälje was  invited by the European Commission’s Joint Research Center to give expert advice on regulatory requirements for safety assessment of nanomedicine. She has also presented her views before the Washington-based ITC (Immunotoxicology Technical Committee, the Health and Environmental Sciences Institute), where Swetox is included along with 34 industry partners, the FDA, and a number of other players.

The goal is to influence the development of specific international guidelines for the assessment of nano-based medicines from an immuno-toxicological perspective because such documentation is missing today.